What Is the Future of the Osgood-Schlatter Market? Key Insights & Growth Outlook According to a newly published market research report by 24LifeSciences, global Osgood-Schlatter disease management market was valued at USD 2,774 million in 2024 and is projected to reach USD 3,282 million by 2032, growing at a compound annual growth rate (CAGR) of 2.5% during the forecast period 2025–2032. Osgood-Schlatter disease (OSD) is a common condition classified as a traction apophysitis of the tibial tuberosity. This essentially means it is an overuse injury causing inflammation at the point where the patellar tendon attaches to the growing tibia bone. The primary manifestations include a painful lump below the kneecap, with symptoms typically worsening during physical activity and improving with rest. This condition predominantly affects adolescents during growth spurts, with epidemiological studies indicating it affects approximately 4% of the adolescent population. Its management is crucial within pediatric orthopedics and sports medicine, focusing on pain relief and maintaining mobility during a critical developmental period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9569/osgood-schlatter-market

FibroTouch Devices Market Size to Reach USD 220 Million by 2032 | Growth Insights Global FibroTouch Devices market is undergoing steady expansion as healthcare systems increasingly prioritize non-invasive diagnostics for liver disease management. Valued at USD 120 million in 2024, the market is projected to grow from USD 132 million in 2025 to USD 220 million by 2032, registering a CAGR of 7.8% during the forecast period. This growth reflects a structural shift away from invasive liver biopsies toward faster, safer, and more patient-friendly elastography-based solutions that deliver real-time clinical insights. The FibroTouch Devices market is gaining prominence across hospitals, diagnostic centers, and specialty clinics as chronic liver conditions such as NAFLD, viral hepatitis, and alcoholic liver disease continue to rise globally. Increasing disease awareness, early screening initiatives, and technological refinements are positioning FibroTouch as a core diagnostic modality in modern hepatology workflows. Access the market report https://www.24lifesciences.com/fibrotouch-devices-market-9969

https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-market

Tiamulin Hydrogen Fumarate Market: Steady Growth to USD 185 Million by 2032, Sustained by Intensive Livestock Production and Disease Management Tiamulin Hydrogen Fumarate Market, valued at USD 120 million in 2024, is projected to reach USD 185 million by 2032, advancing at a CAGR of 5.5% during the forecast period. Support Animal Health and Productivity with Effective Tiamulin Solutions: https://www.24chemicalresearch.com/reports/277532/global-tiamulin-hydrogen-fumarate-market